TARGETED RELEASE RIFAXIMIN COMPOSITIONS
Application
US20260076899A1
Kind: A1
Mar 19, 2026
Assignee
Bausch Health Ireland Limited
Inventors
Jacob Cole, Brian R. Rohrs, Daniel J. Stein, Robert J. Israel, Ezra R. Lowe
Abstract
Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided.
CPC Classifications
A61K 9/0056
A61K 31/137
A61K 31/437
A61K 31/4468
A61K 31/485
A61K 45/06
A61K 47/10
A61K 47/14
A61K 47/32
A61K 47/38
A61P 7/00
A61P 7/04
Filing Date
2025-11-26
Application No.
19402293